[HTML][HTML] Long-term survival and late deaths after allogeneic hematopoietic cell transplantation
JR Wingard, NS Majhail, R Brazauskas… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2011•ncbi.nlm.nih.gov
Purpose Allogeneic hematopoietic cell transplantation (HCT) is curative but is associated
with life-threatening complications. Most deaths occur within the first 2 years after
transplantation. In this report, we examine long-term survival in 2-year survivors in the
largest cohort ever studied.
with life-threatening complications. Most deaths occur within the first 2 years after
transplantation. In this report, we examine long-term survival in 2-year survivors in the
largest cohort ever studied.
Abstract
Purpose
Allogeneic hematopoietic cell transplantation (HCT) is curative but is associated with life-threatening complications. Most deaths occur within the first 2 years after transplantation. In this report, we examine long-term survival in 2-year survivors in the largest cohort ever studied.
ncbi.nlm.nih.gov